Simultaneous Characterization of Somatic Events and HPV-18 Integration in a Metastatic Cervical Carcinoma Patient Using DNA and RNA Sequencing

被引:22
|
作者
Liang, Winnie S. [1 ]
Aldrich, Jessica [1 ]
Nasser, Sara [1 ]
Kurdoglu, Ahmet [1 ]
Phillips, Lori [1 ]
Reiman, Rebecca [1 ]
McDonald, Jacquelyn [1 ]
Izatt, Tyler [1 ]
Christoforides, Alexis [1 ]
Baker, Angela [1 ]
Craig, Christine [2 ]
Egan, Jan B. [3 ]
Chase, Dana M. [2 ]
Farley, John H. [4 ]
Bryce, Alan H. [3 ]
Stewart, A. Keith [3 ]
Borad, Mitesh J. [3 ]
Carpten, John D. [1 ]
Craig, David W. [1 ]
Monk, Bradley J. [5 ]
机构
[1] Translat Genom Res Inst, Phoenix, AZ 85004 USA
[2] St Josephs Hosp, Phoenix, AZ USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ USA
[5] Univ Arizona, St Josephs Hosp & Med Ctr, Creighton Univ, Div Gynecol Oncol,Sch Med,Canc Ctr, Phoenix, AZ USA
基金
美国国家卫生研究院;
关键词
HPV integration; Cervical carcinoma; Next generation sequencing; HUMAN-PAPILLOMAVIRUS; CELL-LINES; CANCER; AMPLIFICATIONS; RETROVIRUS; PARTICLES; MUTATIONS; ALIGNMENT; PIK3CA;
D O I
10.1097/IGC.0000000000000049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Integration of carcinogenic human papillomaviruses (HPVs) into the host genome is a significant tumorigenic factor in specific cancers including cervical carcinoma. Although major strides have been made with respect to HPV diagnosis and prevention, identification and development of efficacious treatments for cervical cancer patients remains a goal and thus requires additional detailed characterization of both somatic events and HPV integration. Given this need, the goal of this study was to use the next generation sequencing to simultaneously evaluate somatic alterations and expression changes in a patient's cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample. Materials and Methods We performed tumor and normal exome, tumor and normal shallow whole-genome sequencing, and RNA sequencing of the patient's lung metastasis. Results We generated over 1.2 billion mapped reads and identified 130 somatic point mutations and indels, 21 genic translocations, 16 coding regions demonstrating copy number changes, and over 36 genes demonstrating altered expression in the tumor (corrected P < 0.05). Sequencing also revealed the HPV type 18 (HPV-18) integration in the metastasis. Using both DNA and RNA reads, we pinpointed 3 major events indicating HPV-18 integration into an intronic region of chromosome 6p25.1 in the patient's tumor and validated these events with Sanger sequencing. This integration site has not been reported for HPV-18. Conclusions We demonstrate that DNA and RNA sequencing can be used to concurrently characterize somatic alterations and expression changes in a biopsy and delineate HPV integration at base resolution in cervical cancer. Further sequencing will allow us to better understand the molecular basis of cervical cancer pathogenesis.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 4 条
  • [1] The integration of HPV-18 DNA in cervical carcinoma
    Corden, SA
    Sant-Cassia, LJ
    Easton, AJ
    Morris, AG
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (05): : 275 - 282
  • [2] STRUCTURE OF HUMAN PAPILLOMAVIRUS DNA (HPV-18) IN CERVICAL-CARCINOMA CELLS
    MAYER, W
    ROGGENBUCK, B
    SCHWARZ, E
    GISSMANN, L
    HAUSEN, HZ
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1985, 260 (04): : 491 - 491
  • [3] Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
    Santin, AD
    Bellone, S
    Gokden, M
    Cannon, MJ
    Parham, GP
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1752 - 1753
  • [4] Discovering HPV16 and HPV18 infection status and cancer gene variations in cervical cancer patient specimens by using Next-generation sequencing.
    Meng, Bo
    Quan, Lili
    Yang, Wenjuan
    Lang, Jidong
    Chen, Lanyou
    Dong, Ruyi
    Zhao, Juanyu
    Tian, Geng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)